Changing T-cell enigma: Cancer killing or cancer control?

national cancer control program; changing strategy?!

0

The Cancer Enigma

Breast Cancer or a Rear Diagnosis

Introduction: Tuberculosis (TB) and its diagnosis are of great importance in the middleeast, according to the increasing burden of this disease and the large number of unreported cases. Less than 20% of all TB cases only have extra-pulmonary manifestations and breast TB is a rare form of extra-pulmonary TB. It includes about 1% of all breast lesions. Case Presentation: This study presents a br...

Breast Cancer or a Rear Diagnosis

Introduction: Tuberculosis (TB) and its diagnosis are of great importance in the middleeast, according to the increasing burden of this disease and the large number of unreported cases. Less than 20% of all TB cases only have extra-pulmonary manifestations and breast TB is a rare form of extra-pulmonary TB. It includes about 1% of all breast lesions. Case Presentation: This study presents a br...

T lymphocytes expressing a CD16 signaling receptor exert antibody-dependent cancer cell killing.

To expand applications for T-cell-based immunotherapy in cancer, we designed a receptor that binds the Fc portion of human immunoglobulins and delivers activation signals. The construct included the high-affinity CD16 (FCGR3A) V158 variant, CD8α hinge, and transmembrane domains, along with signaling domains from CD3ζ and 4-1BB (TNFRSF9), forming a chimeric receptor termed CD16V-BB-ζ. After retr...